Cargando…
c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma
Transforming growth factor (TGF)-β induces cell growth arrest in well-differentiated hepatocellular carcinoma (HCC) while hepatitis B virus X protein (HBx) minimizes the tumor suppression of TGF-β signaling in early chronic hepatitis B. However, how to reverse the oncogenic effect of HBx and sustain...
Autores principales: | WU, YAN-HUI, AI, XI, LIU, FU-YAO, LIANG, HUI-FANG, ZHANG, BI-XIANG, CHEN, XIAO-PING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732859/ https://www.ncbi.nlm.nih.gov/pubmed/26648552 http://dx.doi.org/10.3892/mmr.2015.4644 |
Ejemplares similares
-
c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1
por: Tian, Xiaodong, et al.
Publicado: (2021) -
c-Jun NH2-terminal kinase suppression significantly inhibits the growth of transplanted breast tumors in mice
por: Huang, You-Cheng, et al.
Publicado: (2020) -
Function of the transforming growth factor-β1/c-Jun N-terminal kinase signaling pathway in the action of thalidomide on a rat model of pulmonary fibrosis
por: LIU, XUEJUN, et al.
Publicado: (2014) -
Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1
por: Cai, Shijiao, et al.
Publicado: (2020) -
Selective antagonism of cJun for cancer therapy
por: Brennan, Andrew, et al.
Publicado: (2020)